Smith & Nephew SNATS Revenue 2006-2019 | SNN

Smith & Nephew SNATS annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Smith & Nephew SNATS revenue for the quarter ending December 31, 2019 was $M, a NAN% increase year-over-year.
  • Smith & Nephew SNATS revenue for the twelve months ending December 31, 2019 was $0M, a NAN% increase year-over-year.
  • Smith & Nephew SNATS annual revenue for 2019 was $5.138B, a 4.77% increase from 2018.
  • Smith & Nephew SNATS annual revenue for 2018 was $4.904B, a 2.92% increase from 2017.
  • Smith & Nephew SNATS annual revenue for 2017 was $4.765B, a 2.06% increase from 2016.
Smith & Nephew SNATS Annual Revenue
(Millions of US $)
2019 $5,138
2018 $4,904
2017 $4,765
2016 $4,669
2015 $4,634
2014 $4,617
2013 $4,351
2012 $4,137
2011 $4,270
2010 $3,962
2009 $3,772
2008 $3,801
2007 $3,369
2006 $2,779
2005 $2,562
Smith & Nephew SNATS Quarterly Revenue
(Millions of US $)
2019-12-31
2019-06-30
2018-12-31
2018-06-30
2017-12-31
2017-06-30
2016-12-31
2015-12-31
2015-06-30
2014-12-31 $1,249
2014-09-30 $1,148
2014-06-30 $1,147
2014-03-31 $1,073
2013-12-31 $1,175
2013-09-30 $1,027
2013-06-30 $1,074
2013-03-31 $1,075
2012-12-31 $1,077
2012-09-30 $952
2012-06-30 $1,029
2012-03-31 $1,079
2011-12-31 $1,106
2011-09-30 $1,032
2011-06-30 $1,077
2011-03-31 $1,055
2010-12-31 $1,067
2010-09-30 $941
2010-06-30 $959
2010-03-31 $995
2009-12-31 $1,066
2009-09-30 $915
2009-06-30 $926
2009-03-31 $865
2008-12-31 $960
2008-09-30 $930
2008-06-30 $1,000
2008-03-31 $911
2007-12-31 $967
2007-09-30 $845
2007-06-30 $813
2007-03-31 $744
2006-12-31 $771
2006-09-30 $679
2006-06-30 $686
2006-03-31 $643
2005-12-31 $673
2005-09-30 $609
2005-06-30 $652
2005-03-31 $625
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $17.095B $5.138B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $163.760B 28.40
Medtronic (MDT) Ireland $122.876B 19.96
Stryker (SYK) United States $68.133B 22.11
Boston Scientific (BSX) United States $48.348B 22.73
Baxter (BAX) United States $42.697B 26.06
Lonza Group Ag (LZAGY) Switzerland $42.097B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $29.300B 0.00
Terumo (TRUMY) Japan $28.368B 36.26
ResMed (RMD) United States $27.881B 44.00
Zimmer Biomet Holdings (ZBH) United States $24.546B 15.44
Sunny Optical Technology (SNPTF) China $20.292B 0.00
Bio-Rad Laboratories (BIO) United States $13.860B 63.09
Insulet (PODD) United States $13.102B 1298.06
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
Quidel (QDEL) United States $9.974B 78.38
Shandong Weigao Medical Polymer (SHWGF) China $8.773B 0.00
GN STORE NORD (GNNDY) Denmark $7.628B 38.88
Perrigo (PRGO) Ireland $7.488B 13.40
Hill-Rom Holdings (HRC) United States $7.452B 21.01
William Demant Holdings (WILYY) Denmark $6.296B 0.00
Canopy Growth (CGC) Canada $5.729B 0.00
Haemonetics (HAE) United States $4.502B 27.04
Neogen (NEOG) United States $4.099B 69.43
GW Pharmaceuticals (GWPH) United Kingdom $4.005B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.905B 0.00
ICU Medical (ICUI) United States $3.833B 27.96
Agios Pharmaceuticals (AGIO) United States $3.779B 0.00
Envista Holdings (NVST) United States $3.229B 0.00
NuVasive (NUVA) United States $2.788B 22.39
TG Therapeutics (TGTX) United States $2.629B 0.00
National Vision Holdings (EYE) United States $2.369B 40.99
AtriCure (ATRC) United States $1.744B 0.00
MacroGenics (MGNX) United States $1.548B 0.00
NanoString Technologies (NSTG) United States $1.417B 0.00
Aurora Cannabis (ACB) Canada $1.377B 0.00
Aphria (APHA) Canada $1.233B 0.00
Cerus (CERS) United States $1.159B 0.00
Cardiovascular Systems (CSII) United States $1.072B 0.00
Meridian Bioscience (VIVO) United States $1.049B 39.48
Phibro Animal Health (PAHC) United States $1.015B 20.24
Vapotherm (VAPO) United States $0.971B 0.00
PetIQ (PETQ) United States $0.948B 27.39
DFB Healthcare Acquisitions (AHCO) United States $0.919B 153.00
InMode (INMD) Israel $0.916B 19.36
Zynex (ZYXI) United States $0.875B 87.87
OraSure Technologies (OSUR) United States $0.830B 167.13
Quanterix (QTRX) United States $0.762B 0.00
Omeros (OMER) United States $0.757B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.634B 45.44
VAREX IMAGING (VREX) United States $0.580B 14.40
BioLife Solutions (BLFS) United States $0.574B 163.54
Lantheus Holdings (LNTH) United States $0.572B 11.50
Surmodics (SRDX) United States $0.571B 68.79
LeMaitre Vascular (LMAT) United States $0.528B 30.09
Owens & Minor (OMI) United States $0.486B 12.85
Viemed Healthcare (VMD) United States $0.406B 36.00
Cytosorbents (CTSO) United States $0.369B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.335B 0.00
Utah Medical Products (UTMD) United States $0.313B 22.73
HEXO (HEXO) $0.309B 0.00
Organigram Holdings (OGI) Canada $0.271B 0.00
InfuSystems Holdings (INFU) United States $0.223B 123.67
Female Health (VERU) United States $0.217B 0.00
Chimerix (CMRX) United States $0.193B 0.00
Surface Oncology (SURF) United States $0.176B 0.00
Bovie Medical (APYX) United States $0.164B 0.00
Exagen (XGN) United States $0.145B 0.00
Fonar (FONR) United States $0.136B 12.03
Rockwell Medical (RMTI) United States $0.127B 0.00
United Health Products (UEEC) United States $0.122B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.118B 0.00
Liberty Health Sciences (LHSIF) Canada $0.113B 0.00
Evolus (EOLS) United States $0.113B 0.00
Wound Management Technologies (SMTI) United States $0.105B 0.00
MTech Acquisition (KERN) United States $0.099B 0.00
Chembio Diagnostics (CEMI) United States $0.086B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.079B 0.00
Nephros (NEPH) United States $0.068B 0.00
Capricor Therapeutics (CAPR) United States $0.066B 0.00
United-Guardian (UG) United States $0.066B 15.31
Trinity Biotech (TRIB) Ireland $0.065B 0.00
Brainsway (BWAY) Israel $0.061B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
GUARDION HEALTH (GHSI) United States $0.037B 0.00
FSD PHARMA INC (HUGE) Canada $0.028B 0.00
NF Energy Saving (BIMI) China $0.020B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Myomo (MYO) United States $0.010B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00